CD8A and cancer: The presence of a higher number of infiltrating lymphocytes, particularly cytotoxic CD8+ T cells, within the TME, is associated with better prognosis and improved responses to some cancer treatments like immunotherapy (Badalamenti et al., 2019; Brummel et al., 2023).